- Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
- Browse: 62 Download: 96 Issue Date: 2026-08-18
- Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
- Browse: 57 Download: 124 Issue Date: 2026-08-18
- Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
- Browse: 54 Download: 117 Issue Date: 2026-08-18
- Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
- Browse: 58 Download: 73 Issue Date: 2026-08-18
- Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
- Browse: 44 Download: 80 Issue Date: 2026-08-18
- Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
- Browse: 109 Download: 387 Issue Date: 2026-07-24
- Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
- Browse: 106 Download: 281 Issue Date: 2026-07-24
- Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
- Browse: 104 Download: 289 Issue Date: 2026-07-24
- Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
- Browse: 93 Download: 318 Issue Date: 2026-07-24
- Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
- Browse: 97 Download: 262 Issue Date: 2026-07-24
- Tyrosine kinase inhibitors after progression on atezolizumab-bevacizumab in advanced hepatocellular carcinoma: A systematic review and meta-analysis
- Browse: 157 Download: 516 Issue Date: 2026-06-26
- Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway
- Browse: 135 Download: 374 Issue Date: 2026-06-26
- LECT2/Tie1/Src signaling regulates the oxidative stress response in endothelial cells and liver ischemia-reperfusion injury
- Browse: 124 Download: 488 Issue Date: 2026-06-26
- Emerging treatment options for metabolic dysfunction-associated steatotic liver disease and its related liver diseases
- Browse: 152 Download: 312 Issue Date: 2026-06-26
- Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis
- Browse: 118 Download: 405 Issue Date: 2026-06-26
- Genetic polymorphism of IFI16 and AIM2 among Pakistani hepatitis C virus-induced fibrosis patients
- Browse: 91 Download: 316 Issue Date: 2026-05-26
- Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study
- Browse: 79 Download: 304 Issue Date: 2026-05-26
- Anti-obesity medications, the new frontiers, in metabolic dysfunction-associated fatty liver disease: Efficacy, limitations, and future directions
- Browse: 75 Download: 245 Issue Date: 2026-05-26
- Congenital porto-sinusoidal vascular disorder-induced portal hypertension: A comprehensive review based on a classic clinical case
- Browse: 89 Download: 240 Issue Date: 2026-05-26
- Liver injury after COVID-19 vaccination: Current status and future perspectives
- Browse: 85 Download: 254 Issue Date: 2026-05-26